TEM Stock Tempus AI, Inc.
US · NasdaqGSLast in our picks 2026-10-19 — not in the current list; analysis below is from that screen
Healthcare AI partnerships and precision-medicine growth provide high-upside early-stage exposure.
Future value: $73.56 (+13.65%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Recent analyst upgrades cite expanding healthcare partnerships and accelerating revenue.
- ▾Below 50-day MA (-4.57%)
- ▸Above 200-day MA — long-term uptrend
Is TEM a buy right now?
Trend: TEM is trading below the 50-day average (-4.27%), RSI 42 — neutral momentum, with a 3-month return of +54.57%.
Valuation & quality: Tempus AI, Inc. trades on forward P/E -1429.4, price-to-book 26.84; fundamentals show net margin -17.8%, return on equity -67.4%, revenue growth 21.6% year on year.
Analyst consensus: 18 analysts have a mean 12-month price target of $74.94 (+13% vs the last close; range $35.00 – $100.00), consensus rating “buy”.
Our screen: BUY (score 2) — Healthcare AI partnerships and precision-medicine growth provide high-upside early-stage exposure.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -15.10% | +22.70% | -9.00% | +14.80% | -24.30% | +43.70% | +29.90% | -19.00% |
Fundamentals
Analyst price target
Technical signals
About Tempus AI, Inc.
Tempus AI, Inc. operates as a healthcare technology company in the United States.
Sector: Healthcare · Industry: Health Information Services · United States · 3,800 employees · Website
Related Artificial Intelligence picks
Browse: all US stocks · Artificial Intelligence picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.